Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network

medRxiv(2023)10.1101/2023.01.10.23284397Source: DataRank Database

Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Fagen Xie ORCID,Ruchi Yadav ORCID,Karen J. Wernli ORCID,Emily T. Martin ORCID,Edward A. Belongia ORCID

Live enrichment

PubMed:36711929 OpenAlex:https://openalex.org/W4315629069

National Institutes of Health

Grant: 5UL1TR002243-05

Vanderbilt Institute for Clinical and Translational Research (VICTR)

National Institutes of Health

Grant: 5UL1TR002243-03

Vanderbilt Institute for Clinical and Translational Research (VICTR)

National Institutes of Health

Grant: 3UL1TR001857-07S1

University of Pittsburgh Clinical and Translational Science Institute

NCATS NIH HHS

Grant: UL1 TR001857

NCATS NIH HHS

Grant: UL1 TR002243

greenLicense: CC BY

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/01/11/2023.01.10.23284397.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.01.10.23284397

repositoryhttps://doi.org/10.1101/2023.01.10.23284397

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36711929

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches03 medical and health sciences0302 clinical medicine

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakMedicinePandemicOutbreakInfectious disease (medical specialty)Internal medicineDiseaseAdultCOVID-19 VaccinesSARS-CoV-2Influenza VaccinesOutpatientsHumansCOVID-19Vaccine EfficacyOriginal Articles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being

Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network

FAIR Checklist

Authors (13)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)